Arie Belldegrun

Holdings History for Allogene Therapeutics, Inc. - Common Stock (ALLO)

Symbol: ALLO on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 13,248,170 shares
Security Ownership %: 5.8%

Arie Belldegrun, M.D. ownership in Allogene Therapeutics, Inc. Common Stock (ALLO)

17 Feb 2026 - Arie Belldegrun, M.D. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,248,170 shares of Allogene Therapeutics, Inc. Common Stock (ALLO). This represents 5.8% ownership of the company. In their previous filing dated 13 Nov 2025, Arie Belldegrun had reported owning 12,668,344 shares, indicating an increase of +4.6%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Arie Belldegrun, M.D.	5.8%	+3.3%	$18,149,993	13,248,170	+579,826	+4.6%	$1.37	13G/A	31 Dec 2025	17 Feb 2026, 17:34
Arie Belldegrun, M.D.	5.6%	-1.7%	$15,708,747	12,668,344	+62,450	+0.5%	$1.24	13G/A	30 Sep 2025	13 Nov 2025, 19:09
Arie Belldegrun, M.D.	5.7%	0%	$16,135,544	12,605,894	+62,450	+0.5%	$1.28	13G/A	30 Jun 2025	12 Aug 2025, 16:57
Arie Belldegrun, M.D.	5.7%	-1.7%	$19,316,904	12,543,444	+149,877	+1.2%	$1.54	13G/A	31 Mar 2025	09 May 2025, 17:30
Arie Belldegrun, M.D.	5.8%		$19,086,093	12,393,567			$1.54	13G/A	31 Dec 2024	13 Feb 2025, 16:31